Literature DB >> 18704261

Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population.

Sae Shiota1, Mamoru Tochigi2, Hiroko Shimada2, Jun Ohashi1, Kiyoto Kasai2, Nobumasa Kato2, Katsushi Tokunaga1, Tsukasa Sasaki3,4.   

Abstract

Neuregulin 1 (NRG1) is one of the most promising candidate genes for schizophrenia. A number of replication studies have been conducted, although the results were inconsistent and no susceptible variant has yet been identified. The inconsistency might be attributed to the ethnic difference in allele and haplotype frequencies. However, it is equally possible that one or more genes interacting with NRG1 may also be implicated in schizophrenia and attribute to the inconsistency. To test the hypothesis, we conducted an interaction analysis between NRG1 and one of its receptor's (ERBB4) polymorphisms as well as the association analysis of the two genes associated with schizophrenia in Japanese. We observed no significant difference between patients and controls in allele frequencies or genotypic distributions of the 18 polymorphisms of the genes. The permutation test showed no significant differences in estimated haplotype frequencies between patients and controls, including the haplotype HAP(ICE). In the interaction analysis, significant interaction was observed between rs2919381 in NRG1 and rs7560730 in ERBB4 (P = 0.047, corrected). Thus, our results suggest the possibility that interaction between variants in NRG1 and ERBB4 might contribute to susceptibility for schizophrenia in a Japanese population. Further investigation may be necessary to confirm our results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704261     DOI: 10.1007/s10038-008-0332-9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  30 in total

1.  Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia.

Authors:  J A Badner; E S Gershon
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

2.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

3.  No association with the neuregulin 1 haplotype to Japanese schizophrenia.

Authors:  N Iwata; T Suzuki; M Ikeda; T Kitajima; Y Yamanouchi; T Inada; N Ozaki
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

Review 4.  Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans.

Authors:  Heather J Cordell
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

5.  Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Japanese population.

Authors:  Naoki Fukui; Tatsuyuki Muratake; Naoshi Kaneko; Hideki Amagane; Toshiyuki Someya
Journal:  Neurosci Lett       Date:  2005-12-02       Impact factor: 3.046

6.  Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia.

Authors:  Dawei Li; David A Collier; Lin He
Journal:  Hum Mol Genet       Date:  2006-05-10       Impact factor: 6.150

7.  Schizophrenia is not associated with the functional candidate gene ERBB3: results from a case-control study.

Authors:  Tetsufumi Kanazawa; Stephen J Glatt; Atsushi Tsutsumi; Hiroki Kikuyama; Jun Koh; Hiroshi Yoneda; Ming T Tsuang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-01-05       Impact factor: 3.568

8.  Association study of neuregulin 1 gene with schizophrenia.

Authors:  J Z Yang; T M Si; Y Ruan; Y S Ling; Y H Han; X L Wang; M Zhou; H Y Zhang; Q M Kong; C Liu; D R Zhang; Y Q Yu; S Z Liu; G Z Ju; L Shu; D L Ma; D Zhang
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

9.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  15 in total

1.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

Review 2.  Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Authors:  Anamika Banerjee; Mathew L Macdonald; Karin E Borgmann-Winter; Chang-Gyu Hahn
Journal:  Brain Res Bull       Date:  2010-04-28       Impact factor: 4.077

3.  ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children.

Authors:  Vanessa Douet; Linda Chang; Kristin Lee; Thomas Ernst
Journal:  Brain Imaging Behav       Date:  2015-03       Impact factor: 3.978

4.  Schizophrenia candidate gene ERBB4: covert routes of vulnerability to psychosis detected at the population level.

Authors:  Nicholas C Stefanis; Alex Hatzimanolis; Nikolaos Smyrnis; Dimitrios Avramopoulos; Ioannis Evdokimidis; Jim van Os; Costas N Stefanis; Richard E Straub; Daniel R Weinberger
Journal:  Schizophr Bull       Date:  2011-11-24       Impact factor: 9.306

5.  Evaluation of polygenic risks for narcolepsy and essential hypersomnia.

Authors:  Maria Yamasaki; Taku Miyagawa; Hiromi Toyoda; Seik-Soon Khor; Xiaoxi Liu; Hitoshi Kuwabara; Yukiko Kano; Takafumi Shimada; Toshiro Sugiyama; Hisami Nishida; Nagisa Sugaya; Mamoru Tochigi; Takeshi Otowa; Yuji Okazaki; Hisanobu Kaiya; Yoshiya Kawamura; Akinori Miyashita; Ryozo Kuwano; Kiyoto Kasai; Hisashi Tanii; Tsukasa Sasaki; Yutaka Honda; Makoto Honda; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2016-06-16       Impact factor: 3.172

Review 6.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

Review 7.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

8.  Exonic DNA sequencing of ERBB4 in bipolar disorder.

Authors:  Fernando S Goes; Michael Rongione; Yun-Ching Chen; Rachel Karchin; Eran Elhaik; James B Potash
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

9.  Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system.

Authors:  Kuo-Chuan Huang; Ko-Chun Yang; Han Lin; Theresa Tsao Tsun-Hui; Wen-Kuei Lee; Sheng-An Lee; Cheng-Yan Kao
Journal:  BMC Genomics       Date:  2013-10-16       Impact factor: 3.969

10.  Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.

Authors:  N Takahashi; T Sakurai; O Bozdagi-Gunal; N P Dorr; J Moy; L Krug; M Gama-Sosa; G A Elder; R J Koch; R H Walker; P R Hof; K L Davis; J D Buxbaum
Journal:  Transl Psychiatry       Date:  2011-05-10       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.